Search Results 51-60 of 14148 for Lupus

  1. A Study of the Safety and Tolerability of JNJ-55920839, Either as a Single Ascending Dose in Healthy Individuals or as Multiple Doses for Patients who have Mild to Moderate Systemic Lupus Erythematosus - Mayo Clinic

    ... Lupus International Collaborating Clinics (SLICC) criteria for diagnosis of lupus ... Has active Central nervous system (CNS) lupus or history of severe CNS lupus ...

  2. Autoimmune hepatitis - Symptoms and causes - Mayo Clinic

    This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.

  3. Mayo Clinic: Big Toe Isn't Biggest Culprit in Gout Flare-Ups; Other Joints Tied to Higher Risk

    In other findings, Mayo discovered a clue to why lupus tends to be worse in African-Americans; chronicled erratic blood pressure in rheumatoid arthritis ...

  4. Optic neuritis - Symptoms & causes - Mayo Clinic

    Besides MS , optic nerve inflammation can occur with other conditions, including infections or immune diseases, such as lupus. Rarely, another disease ...

  5. Scleroderma - Symptoms and causes - Mayo Clinic

    People who have scleroderma also may have symptoms of another autoimmune disease such as rheumatoid arthritis, lupus or Sjogren syndrome. Complications.

  6. A Study to Assess Omega-3 Replacement With Krill Oil in Disease Management of System Lupus Erythematosus (SLE) - Mayo Clinic

    The purpose of this study is to test the hypothesis that subjects with active System Lupus Erythematosus (SLE) will benefit from correcting their omega-3 ...

  7. Uma Thanarajasingam, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Uma Thanarajasingam, M.D., Ph.D., studies translational study of systemic lupus erythematosus and rheumatic immune-related adverse events at Mayo Clinic.

  8. A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of Caba-201 in Subjects With Active Systemic Lupus Erythematosus - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of CABA-201 in subjects with active Systemic Lupus Erythematosus. Participation eligibility.

  9. Crafting An Artist's Healthy Future - Mayo Clinic News Network

    Lupus was wreaking havoc on Emily Olson's health. Her Mayo Clinic care team's decision to employ a medication typically not used for this autoimmune disorder, ...

  10. A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis - Mayo Clinic

    A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis ... lupus nephritis (LN) when ...